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Introduction
In eukaryotic cells, sterols reside in all compartments but are 
unevenly distributed. Cholesterol (ergosterol in yeast) is syn-
thesized in the ER, but is rare in this compartment and more 
concentrated at the trans Golgi, endosomes, and the plasma 
membrane (PM). Sterols are transferred between organelles 
either by transport vesicles or by soluble carriers (Maxfield and 
Tabas, 2005; Prinz, 2007; Mesmin and Maxfield, 2009). In 
yeast, ergosterol moves from the ER to the PM mostly via protein-
mediated nonvesicular routes (Baumann et al., 2005). Little is 
known about the identity of the carriers, but oxysterol-binding 
homology protein (Osh) are plausible candidates (Prinz, 2007; 
Fairn and McMaster, 2008; Lev, 2010). Suppression of the 
entire Osh family is lethal, depriving the PM in ergosterol and 
stopping endocytosis. Conversely, expressing any of the seven 
Osh restores cell viability (Beh and Rine, 2004).
Osh4p, also known as Kes1p, is the simplest and best 
characterized Osh. Its structure consists of a -barrel form-
ing a sterol-binding pocket (Im et al., 2005). When Osh4p is 
empty, the N-terminal segment (29 amino-acids) is unfolded 
and leaves the pocket open. Upon sterol binding, this segment 
forms a lid that blocks the sterol molecule in the pocket. Thus, 
Osh4p seems adapted to transport sterols (Levine, 2005) and, 
in accord with this, was found to move sterol between artificial 
membranes (Raychaudhuri et al., 2006). Because all Osh pro-
teins and the human oxysterol-binding protein-related protein 
(Orp;  Ridgway,  2010)  contain  a  sterol-binding  domain  akin 
to Osh4p, better understanding the sterol transport activity of 
Osh4p should have general implications.
O
sh/Orp proteins transport sterols between or-
ganelles and are involved in phosphoinositide 
metabolism. The link between these two aspects 
remains elusive. Using novel assays, we address the influ-
ence of membrane composition on the ability of Osh4p/
Kes1p to extract, deliver, or transport dehydroergosterol 
(DHE). Surprisingly, phosphatidylinositol 4-phosphate 
(PI(4)P) specifically inhibited DHE extraction because PI(4)P 
was itself efficiently extracted by Osh4p. We solve the 
structure of the Osh4p–PI(4)P complex and reveal how 
Osh4p  selectively  substitutes  PI(4)P  for  sterol.  Last,  we   
show that Osh4p quickly exchanges DHE for PI(4)P and, 
thereby, can transport these two lipids between mem-
branes along opposite routes. These results suggest a model 
in which Osh4p transports sterol from the ER to late com-
partments pinpointed by PI(4)P and, in turn, transports 
PI(4)P backward. Coupled to PI(4)P metabolism, this trans-
port cycle would create sterol gradients. Because the residues 
that recognize PI(4)P are conserved in Osh4p homologues, 
other Osh/Orp are potential sterol/phosphoinositol phos-
phate exchangers.
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How Osh4p binds PI(4)P is not well understood. Osh4p does 
not have any known phosphoinositol phosphate–binding domain, 
and in vitro binding assays failed to prove that Osh4p could 
distinguish a PI(4)P- from a PI(4,5)P2-containing membrane 
(Li et al., 2002; Fairn and McMaster, 2005; Schulz et al., 2009). 
Moreover, no link between PI(4)P and sterol transport by Osh4p 
has been found. Here, using a combination of assays for lipid 
exchange  and  x-ray  crystallography,  we  solve  this  issue  by 
showing that Osh4p acts as a sterol/PI(4)P exchanger.
Results
Osh4p quickly extracts and solubilizes the 
fluorescent ergosterol dehydroergosterol 
(DHE) from neutral liposomes
So far, the ability of Osh4p to extract, deliver, or exchange 
sterols  has  been  mostly  tested  using  radiolabeled  sterols 
(Raychaudhuri et al., 2006; Schulz et al., 2009). However, the 
separation procedures required for determining the sterol dis-
tribution between the donor liposomes, the acceptor liposomes, 
and the protein do not permit precise kinetics measurements. 
To  circumvent  these  limitations,  we  took  advantage  of  the 
fluorescence properties of DHE, a natural ergosterol analogue. 
We observed that the intrinsic fluorescence of Osh4p quickly 
diminished once added to large liposomes made of dioleoyl 
phosphatidylcholine (DOPC) doped with 0.5% DHE (Fig. 1 A). 
Spectral analysis revealed that tryptophan quenching at 340 nm 
was concomitant with the apparition of three emission peaks at 
To properly allocate sterol in the cell, Osh/Orp must en-
sure a one-way transport of sterol between defined compart-
ments. This seems the simplest way to enrich one membrane 
with sterol at the expense of another. Such transport must in-
volve transient and sequential interactions between the protein, 
the sterol molecule, and two lipid bilayers, one acting as a donor 
membrane and one as an acceptor (Lev, 2010). Osh4p adopts 
two different structures depending on its state (empty or sterol-
bound), and this is likely critical for proper protein targeting to 
donor and acceptor membranes during a cycle of transport. In 
line with this hypothesis, Osh4p has been proposed to transport 
sterol from the PM to the ER (Raychaudhuri et al., 2006). A key 
argument is that sterol uptake in vitro is facilitated by phospha-
tidylinositol (PI) 4,5 bisphosphate (PI(4,5)P2), a PM lipid.
However, control of Osh4p by PI(4,5)P2 is hard to recon-
cile with other observations. First, the level of ergosterol at the 
PM increases upon Osh4p expression (Beh et al., 2001). Sec-
ond, genetic and cellular studies suggest that Osh4p has a specific 
function at the Golgi, and that this function depends on another 
phosphoinositide, PI 4-phosphate (PI(4)P), present at the trans 
side. Osh4p is the only Osh whose expression is lethal in 
Sec14p-deficient yeast (Fang et al., 1996; Li et al., 2002). Sec14p 
is a key protein, which maintains a lipid composition permis-
sive for vesicular transport (Bankaitis et al., 2005). In the ab-
sence of Sec14p, the amount of PI(4)P is limiting. Osh4p, whose 
endogenous expression is high, monopolizes all remaining 
PI(4)P molecules at the expense of essential proteins of vesicu-
lar transport (Fairn et al., 2007; LeBlanc and McMaster, 2010). 
Figure 1.  Real-time measurement of DHE load-
ing and extraction by Osh4p from large DOPC 
liposomes. (A) Intrinsic fluorescence at 340 nm 
of Osh4p (0.5 µM) upon addition to DOPC/
DHE (99.5:0.5 mol/mol) liposomes (blue trace) 
or to DOPC liposomes (black trace). The final 
lipid concentration is 0.5 mM. (B) Fluorescence 
emission spectra (ex = 285 nm) of the samples 
shown in A at the end of the kinetics. (C) Close-up   
view of the Osh4p structure (PDB accession no. 
1ZHZ) showing the lid (segment 1–29, black) 
covering  ergosterol  (bright  green).  Trypto-
phans located at ≤15 Å, between 15 and 
20 Å, or at ≥20 Å from ergosterol are colored 
in cyan, blue, and purple, respectively. Cystein 
C98 is indicated. (D) Fluorescence at 510 nm 
(ex = 310 nm) of 0.5 µM DNS-Osh4p added 
to buffer alone (gray trace) or to DOPC/DHE 
(99.5:0.5 mol/mol, blue trace), DOPC (black 
trace),  DOPC/ergosterol  (95:5,  light  green 
trace), or DOPC/ergosterol/DHE (94.5:5:0.5, 
dark  green  trace)  liposomes.  Bottom  trace, 
unlabeled  Osh4p  added  to  DOPC/DHE  lipo-
somes. (E) 0.5 µM Osh4p was incubated with 
DOPC  or  DOPC/DHE  (99.5:0.5)  liposomes 
(0.5 mM lipids) filled with sucrose. A reference 
experiment  (100%)  was  done  without  lipo-
somes. After centrifugation, the percentage of 
Osh4p in the pellet (P) and supernatant (S) was 
determined  by  SDS-PAGE.  The  fluorescence 
spectrum of each sample was recorded (ex =   
285  nm).  Control  spectra  corresponding  to 
buffer or liposome alone (0.5 mM lipids) were 
subtracted from the spectra of the supernatant 
and pellet, respectively. Data in E are from a 
single representative experiment out of two in-
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caused much less retention of Osh4p on the liposomes (8–10%). 
Surprisingly, the fluorescence spectra of the supernatants re-
vealed a major difference: with PI(4)P, Osh4p failed to fully 
extract DHE (I372/I340 = 1.08). In contrast, DHE loading in the 
presence of PI(4,5)P2 was complete and similar to that observed 
on pure DOPC liposomes. This suggested that PI(4)P specifi-
cally inhibits DHE extraction.
The fact that PI(4)P had a specific inhibitory effect on 
Osh4p was striking in real-time measurements. As mentioned 
previously (Fig. 1 A), we recorded the rate of DHE extraction 
by Osh4p by measuring the quenching of tryptophan at 340 nm.   
In addition, we measured Osh4p binding to the liposomes through 
a second and independent fluorescence signal at 525 nm. To 
this end, we labeled the ALPS/lid motif with 7-nitrobenz-
2-oxa-1,3-diazol (NBD), a probe whose fluorescence increases 
upon insertion between lipids. Control experiments indicated 
that this probe was well positioned to measure liposome bind-
ing of Osh4p (Fig. S2). As shown in Fig. 2 B, PI(4)P at 2 mol% 
354, 373, and 393 nm (Fig. 1 B). These peaks are characteristic 
of DHE, which suggests fluorescence resonance energy transfer   
(FRET) from Osh4p to DHE (Schroeder et al., 1990; Holt et al., 
2008; Liu et al., 2009). Osh4p contains several tryptophans 
close to the ergosterol-binding pocket, which should be respon-
sible for the observed FRET signal (Fig. 1 C).
Next, we created a more defined FRET pair by labeling 
an  endogenous  cysteine  (C98)  with  a  dansyl  (DNS)  probe. 
C98 is exposed on the external side of Osh4p, at 12.8 Å from 
the center of the sterol-binding pocket. Once DNS-Osh4p was 
added to DHE-containing liposomes, the fluorescence of DNS 
at 510 nm upon DHE excitation increased with kinetics similar 
to tryptophan quenching by DHE (1/t1/2 of 0.13 and 0.18 s
1, 
respectively; Fig. 1, A and D). No FRET was observed when 
Osh4p or DNS-Osh4p was mixed with liposomes lacking DHE 
or combining DHE and an excess of nonfluorescent ergosterol 
(Fig. 1, A and D). Therefore, the two FRET signals presented in 
Fig. 1 monitor the loading of DHE by Osh4p.
The experiments shown in Fig. 1 (A and D) did not allow 
us to determine whether Osh4p remained bound to the lipo-
somes or returned in solution after DHE extraction. To dis-
tinguish between these two possibilities, we incubated Osh4p 
with sucrose-loaded DOPC liposomes containing DHE. After 
15 min, the liposomes were collected by centrifugation. Gel 
and spectral analysis indicated that the protein was mostly re-
covered in the supernatant and quenched by DHE (Fig. 1 E). 
No spectral change was observed with DHE-free liposomes 
(Fig. 1 E) or when a “lidless” form of Osh4p lacking the am-
phipathic lipid packing sensor (ALPS)/lid motif and deficient 
in sterol binding was used (Fig. S1; Im et al., 2005; Raychaudhuri 
et al., 2006). We concluded that Osh4p interacts transiently 
with neutral liposomes, traps sterol, and goes back in solution 
in a sterol-loaded form stabilized by the lid. “Extraction” will 
be used to indicate DHE loading regardless of the retention of 
Osh4p on membranes, whereas “solubilization” will be used 
to indicate that Osh4p not only extracts DHE but also dissoci-
ates from membranes.
Effect of anionic lipids on DHE 
solubilization by Osh4p
It has been reported that PI(4,5)P2 specifically stimulates sterol 
extraction by Osh4p (Raychaudhuri et al., 2006). We used our 
assay combining sedimentation and fluorescence analysis to 
examine the effect of various anionic lipids on the ability of Osh4p 
to extract and solubilize DHE (Fig. 2 A). To have an index of 
DHE binding by Osh4p, we calculated for both the liposome 
pellet and the supernatant an intensity ratio I372/I340, which re-
flects the extent of FRET between Osh4p and DHE in these 
fractions (from 0.5 for DHE-free Osh4p to 1.9 for Osh4p satu-
rated with DHE).
Anionic lipids had contrasting effects on the extraction 
and solubilization of DHE by Osh4p. First, dioleoyl phosphati-
dylserine (DOPS), which was used at 30 mol%, caused strong 
retention of Osh4p to the liposomes but did not modify the ex-
tent of DHE extraction. Both the soluble and the membrane-
bound forms of Osh4p were loaded with DHE (I372/I340 = 1.81 
and 1.94). PI(4)P or PI(4,5)P2, which were both used at 2 mol%, 
Figure 2.  Influence of membrane composition on the solubilization of 
DHE by Osh4p. (A) Solubilization of DHE by Osh4p from DOPC liposomes 
doped with the indicated anionic lipid using the same protocol as in   
Fig. 1 E. When the fluorescence intensity was high enough, the I372/I340 
ratio, which reflects the amount of DHE in complex with Osh4p in the 
supernatant (S) or in the pellet (P), was determined. (B) 0.5 µM NBD-Osh4p 
was added to buffer (lip) or to liposomes (0.5 mM lipids) of various 
compositions. Trp fluorescence was monitored at 340 nm (ex = 285 nm; 
top), whereas NBD fluorescence was followed at 525 nm (ex = 495 nm; 
bottom). The contribution of the liposomes to the fluorescence signal was 
subtracted for each curve, and the fluorescence in buffer at t = 0 was 
used as a reference for normalization. Data shown in A are from a single 
representative experiment out of two independent experiments.JCB • VOLUME 195 • NUMBER 6 • 2011   968
PI(4)P caused Osh4p liposome binding (1–5 mol%) indicated 
that PI(4)P blocked DHE uptake by a mechanism different 
from membrane retention.
Consequently, we hypothesized that PI(4)P could be itself 
extracted by Osh4p. As such, PI(4)P would act as a competing 
inhibitor of DHE. This mechanism would explain why Osh4p 
was recovered in the supernatant in the presence of PI(4)P, but 
did not show strong DHE loading (Fig. 2 A). To test this hypoth-
esis, we incubated sucrose-loaded DOPC liposomes containing 
radiolabeled PI(4)P with an increasing amount of Osh4p. At   
5 µM, Osh4p extracted 40%, i.e., 4 µM of PI(4)P (Fig. 3 B). 
Considering the amount of lipids (10 µM PI(4)P) and the fact 
that only half was accessible (in the liposome outer leaflet), 
this suggested that Osh4p extracted a stoichiometric amount of 
PI(4)P. In line with this, the dose response curves of cholesterol 
and PI(4)P extraction were very similar. In contrast, less PI or 
PI(4,5)P2 was extracted (Fig. 3 B).
In yeast, Osh4p inhibits the recruitment at the Golgi of 
a reporter protein for PI(4)P under conditions where this lipid 
is limiting (Fairn et al., 2007). Extraction of PI(4)P by Osh4p 
could explain this observation. We tested this model using a 
two-stage assay. In the first stage, liposomes containing 2 mol% 
PI(4)P were incubated with Osh4p and recovered at the top 
of a sucrose gradient by centrifugation. In the second stage, the 
liposomes were incubated with a GST-tagged Pleckstrin homology 
domain that targets PI(4)P (PHFAPP, 0.75 µM). In the absence of 
Osh4p during the first stage, almost all PHFAPP was recovered 
on the liposomes. When Osh4p was included at a concentration   
(10 µM) exceeding the amount of accessible PI(4)P (7.5 µM), 
binding of PHFAPP was low and undistinguishable from that ob-
served on pure DOPC liposomes (Fig. 3 C). When the concentra-
tion of Osh4p (5 µM) was below the concentration of accessible 
almost completely blocked DHE extraction by NBD-Osh4p (red 
trace). In contrast, DOPS and PI(4,5)P2 had no effect on the   
extent of DHE loading and, instead, accelerated the rate of sterol   
extraction. Intriguingly, when the binding of Osh4p to the lipo-
somes was measured by NBD fluorescence, PI(4)P did not contrast 
with other anionic lipids. In agreement with the sedimentation 
assay (Fig. 2 A), the NBD intensity was minimal with neutral 
liposomes, slightly increased with 2 mol% PI(4)P or 2 mol% 
PI(4,5)P2, and became maximal with liposomes containing a 
large amount of DOPS (30 mol%).
In conclusion, anionic lipids affect DHE extraction/ 
solubilization by Osh4p in very different ways: by stimulating 
the rate of sterol extraction (2% PI(4,5)P2; 30% DOPS), by re-
taining the protein on the liposome surface (30% DOPS), or by 
inhibiting DHE extraction (2% PI(4)P). The most surprising 
observation was the inhibitory effect of PI(4)P.
Osh4p specifically extracts PI(4)P  
from liposomes
To further study the inhibitory effect of PI(4)P on DHE extrac-
tion by Osh4p, we performed experiments at increasing surface 
density of PI(4)P. The amount of DHE was kept at 0.5 mol%.   
As shown in Fig. 3 A, PI(4)P inhibited DHE extraction by 
NBD-Osh4p with a half-maximal effect of 0.5–1 mol%. No 
inhibition was seen with PI(4,5)P2, even at 5 mol%. Interest-
ingly, NBD fluorescence indicated negligible protein retention 
on the liposomes when the density of PI(4)P did not exceed   
1 mol%. At higher density (1–5 mol%), PI(4)P recruited Osh4p 
on membranes with similar efficiency as PI(4,5)P2, which sug-
gests nonspecific electrostatic interactions. The lack of correla-
tion between the concentration range at which PI(4)P inhibited 
DHE loading (0–2 mol%) and the concentration range at which 
Figure 3.  DHE and PI(4)P compete for extraction by Osh4p. (A) 0.5 µM NBD-Osh4p was added to buffer alone or to DOPC liposome (0.5 mM lipids) 
containing 0.5 mol% DHE and increasing amounts of PI(4)P or PI(4,5)P2. The changes in Trp and NBD fluorescence, which reflect DHE extraction and 
liposome binding, respectively, were monitored as in Fig. 2 B. The plots show the fluorescence levels 9 min after the addition of Osh4p. The amount of 
DHE-free Osh4p reported on the right axis was determined from the Trp intensity. (B) Lipid extraction assay. Sucrose-loaded DOPC liposomes (0.5 mM 
lipids) containing 2% PI(4)P (red curve), 2% PI(4,5)P2 (green curve), 2% PI (purple curve), or 2% cholesterol (black curve) and doped, respectively, with 
[
32P]PI(4)P, [
3H]PI(4,5)P2, [
3H]PI, or [
3H]cholesterol were incubated with Osh4p (0–5 µM) for 20 min (room temperature). After centrifugation, radioactivity 
in the supernatant and in the pellet was counted to calculate the fraction of extracted lipid. Data are represented as mean ± SEM (error bars; n = 2–3). 
(C) Two-stage flotation assay. DOPC liposomes containing the indicated amounts of PI(4)P and DHE were mixed with 0, 5, or 10 µM Osh4p, collected 
by flotation, and then incubated with 0.75 µM PHFAPP (GST-tagged). The final amount of liposome-bound Osh4p and PHFAPP after the second stage was 
determined by SDS-PAGE. (D) Solubilization of DHE by Osh4p from DOPC liposomes containing 2% PI(4)P and increasing amounts of DHE (0–10%). 
After centrifugation, the amount of protein in the supernatant (top) was assessed by SDS-PAGE. The bottom shows Osh4p fluorescence at 340 nm (ex =   
285 nm). Data are represented as mean ± SEM (error bars; n = 2). For comparison, an experiment was performed with liposomes containing 0.5% DHE 
but no PI(4)P (black curve).969 Osh4p is a sterol/PI(4)P transporter • de Saint-Jean et al.
hydrogen-bonds with the side-chains of H143, H144 (4-5), 
and R344 (7), and a water-mediated interaction with the main 
chain oxygen atom of S25 from the lid. The 1-phosphate group 
bridging the inositol ring and the glycerol moiety is hydrogen 
bonded to K109 (2), K336 (7), and the backbone amide of 
A29 in the lid (Fig. 4 E). Finally, the hydroxyl groups of the 
inositol ring are engaged in direct or water-mediated hydrogen 
bonds with the main chain oxygen atoms of S25, L27 (lid), 
and N112 (2-3 loop), and with the side chain of E340 (7). 
Molecular  modeling  suggested  that  Osh4p  could  not  bind 
PI(4,5)P2 as the 5-phosphate group should sterically clash with 
the side-chain of H143 (Fig. S3 B). A phosphate at position 3 
seems also unfavorable.
We noted that several residues making contact with the 
PI(4)P headgroup are strictly conserved in Osh/Orp proteins. 
We tested their functional role by examining the inhibitory 
effect of PI(4)P on DHE loading by Osh4p mutants (Fig. 4 F). 
The mutants K109A, N112E, H143A/H144A, E340A, R344A, 
and K336A loaded DHE from liposomes as efficiently as the 
wild-type form but were not inhibited by PI(4)P. As a con-
trol,  mutating  basic  residues  (K174A,  K407A/K411A,  and 
K247A/R249A) on the other side of the sterol pocket preserved 
both the ability of Osh4p to extract DHE and its inhibition by 
PI(4)P. Finally, we noted that loop 204–212, which is defined 
in the sterol-bound form of Osh4p but not in the Osh4p–PI(4)P 
complex, is likely key for sterol binding but not for PI(4)P: the 
H202A/E204A mutant loaded DHE very slowly but remained 
sensitive to PI(4)P.
Osh4p delivers DHE to PI(4)P-containing 
acceptor liposomes
The crystal structures of Osh4p demonstrate that sterols and 
PI(4)P are mutually exclusive ligands, which explains why they 
compete for Osh4p extraction when present in the same mem-
brane. However, this observation does not necessarily imply 
that sterol and PI(4)P act in an antagonist manner. In the context 
of lipid transport, Osh4p might exchange sterol for PI(4)P such 
that forward transport of sterol between two membranes would 
be coupled to backward transport of PI(4)P.
As  a  first  step  toward  testing  this  hypothesis,  we  per-
formed DHE delivery assays. We prepared Osh4p loaded with 
DHE (Osh4p[DHE]), then followed the kinetics of DHE release 
upon the addition of acceptor liposomes by measuring the in-
crease in tryptophan fluorescence of Osh4p that resulted from 
the loss of FRET with DHE. With liposomes containing 2% 
PI(4)P, a jump in the fluorescence of Osh4p[DHE] was ob-
served. The signal increase (2.6×) mirrored the signal decrease 
observed when Osh4p extracted DHE (1/2.5×; Fig. 1 A), which 
suggests the complete release of DHE. The effect of PI(4)P was 
very specific. Substituting other anionic lipids for PI(4)P such 
as DOPS, PI, PI(3)P, PI(5)P, or PI(4,5)P2 resulted in minor DHE 
release (Fig. 5 A).
DHE delivery probably involves sequential steps: binding 
of Osh4p[DHE] to the liposome surface, opening of the lid, and 
the exit of DHE. To better define this sequence of events and 
the role of PI(4)P, we compared experiments in which DNS-
Osh4p[DHE]  was  mixed  with  acceptor  liposomes  with  or 
PI(4)P, PHFAPP bound efficiently to the liposomes (Fig. 3 C). 
Importantly, under all conditions, the final amount of liposome-
bound Osh4p was low and nearly identical. These observations 
suggested that Osh4p can extract a stoichiometric amount of 
PI(4)P, thereby preventing the subsequent binding of PHFAPP to 
the liposomes. Last, when 10% mol DHE was included in the 
liposome formulation, binding of PHFAPP to the liposomes was 
no longer affected by preincubation with Osh4p. By compet-
ing with PI(4)P, DHE in excess likely prevented Osh4p from 
extracting PI(4)P.
As  previously  mentioned,  PI(4)P  inhibited  the  loading 
of 0.5 mol% DHE by Osh4p with a half-maximal effect of   
0.5–1 mol% (Fig. 3 A). Conversely, when the surface density of 
PI(4)P was kept at 2 mol%, the dose response curve of DHE load-
ing was shifted to higher density values (half-maximal effect = 
2 mol%; Fig. 3 D). Therefore, PI(4)P and DHE act not only as 
competing ligands for extraction by Osh4p, but they also dis-
play similar affinities for the protein.
Structural basis of PI(4)P-specific 
recognition by Osh4p
Because PI(4)P competes with DHE, the PI(4)P-binding site in 
Osh4p should overlap with the sterol-binding pocket. Using   
in silico approaches, we noticed that the sterol-binding site may 
also house a PI(4)P molecule. This prompted us to perform 
structural studies.
We crystallized Osh4p with PI(4)P and solved the struc-
ture of the complex by molecular replacement at 2.6-Å reso-
lution (Table S1). The overall structure of Osh4p (Fig. 4 A) 
displays a central near-complete -barrel (residues 117–307) 
forming a mainly hydrophobic tunnel flanked by an N-terminal   
domain (residues 30–116), which consists of a two-stranded 
-sheet and three -helices that close the incomplete -barrel, 
and a large C-terminal region (residues 308–434). With a root 
mean square deviation (rmsd) of 1.14 Å for 382 residues, the 
structure of the complex with PI(4)P is highly similar to that ob-
tained in the presence of ergosterol (PDB accession no. 1ZHZ;   
Fig. 4 B; Im et al., 2005). However, the lid (residues 1–29) adopts 
another  conformation  to  accommodate  the  PI(4)P  molecule   
(Fig. 4 B). In addition, several regions of the protein display 
poor electron density and could not be modeled reliably. These 
unresolved segments in the PI(4)P-bound conformation corre-
spond to loops 99–105, 172–175, 204–212, and 237–242, and 
to the N-terminal part of the lid (1–12; Fig. 4, A and B).
PI(4)P binds to Osh4p by inserting its two acyl chains 
into the central tunnel of the -barrel while the phosphory-
lated inositol ring lies near the protein surface in a shallow 
pocket formed by residues from the C-terminal loop of the 
lid, strand 2, the tip of the turn 4-5, and helix 7 (Fig. 4,   
A and C). The acyl chains of PI(4)P interact loosely with the 
sterol-binding site in a rather nonspecific manner, as suggested 
by the faint electron density observed for this part of the ligand 
(Fig. 4 D and Fig. S3 A). At the opposite, the polar head group 
is involved in many direct and water-mediated contacts with 
the protein, accounting for the specific recognition of PI(4)P 
by Osh4p and the well-defined electron density of this part 
of the ligand (Fig. 4 E). The 4-phosphate group makes direct JCB • VOLUME 195 • NUMBER 6 • 2011   970
Figure 4.  Crystal structure of Osh4p in complex with 
PI(4)P. (A) Overall structure. The lid region is shown in   
red (residues 13–29), the N-terminal domain in orange   
(30–116), the -barrel in green (117–307), and the 
C-terminal domain in cyan (308–434). PI(4)P is shown 
as spheres with carbon atoms colored in white, oxy-
gen in red, and phosphorus in orange. The missing 
loops are represented by dashed lines. (B) Structure 
superposition  of  Osh4p  in  complex  with  PI(4)P  (in 
orange) or ergosterol (in purple; PDB accession no. 
1ZHZ). The black circle indicates the region that differs 
significantly in the two structures. (C) Close-up view of 
the PI(4)P binding site. PI(4)P is shown in black with 
oxygen in red and phosphorus in orange. (D) Super-
position of PI(4)P (colored in orange) and ergosterol 
(purple) molecules in Osh4p. The backbone of Osh4p 
is shown in light gray. (E) Stereo view of the interaction 
network of the PI(4)P polar head. The electron density 
colored in blue represents the Fo-Fc–simulated anneal-
ing omit map contoured at 2.5 . Nitrogen, oxygen, 
and phosphorus atoms are shown in blue, red, and 
orange, respectively. Key water molecules contacting 
PI(4)P and the protein are displayed as cyan spheres. 
(F) Effect of mutations on the ability of Osh4p to extract 
DHE from DOPC liposomes doped or not doped with 
2% PI(4)P. The experimental conditions were the same 
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contained only DOPC or were doped with 2 mol% phospha-
tidylserine,  PI,  or  PI(3)P,  DHE  transport  was  very  slow   
(<1 nmol/min). In the presence of 2 mol% PI(4,5)P2 or PI(5)P, 
the rate increased approximately fourfold. Finally, with accep-
tor liposomes containing 2 mol% PI(4)P, we observed the fast-
est initial rate of transport (11 nmol /min; Fig. 6 A). Thus, there 
was a good correlation between the transport rate under multi-
ple turnover conditions and the ability of Osh4p to deliver DHE 
to acceptor liposomes (Fig. 5 A).
Next we tested the DHE transfer activity of several Osh4p 
mutants with donor liposomes made of DOPC and acceptor lipo-
somes containing DOPC and 0, 1, or 2 mol% PI(4)P (Fig. 6 B). 
In the absence of PI(4)P, the transport activity of all mutants was 
as low as that of wild-type Osh4p. Marked differences emerged 
when the acceptor membranes included PI(4)P. Some mutants 
(K109A,  E340A,  R344A,  and  N112E)  showed  a  modest  de-
crease in activity (two- to threefold) compared with the wild-type 
form, whereas the K336A and H143A/H144A mutant showed a 
much stronger defect (five- and ninefold, respectively). Remark-
ably, these two mutants were almost as inactive as lidless Osh4p 
([30–434]Osh4p) defective in sterol binding. Because K336A 
and H143A/H144A extracted DHE normally but did not respond 
to PI(4)P (Fig. 4 F), these results highlighted the importance of 
PI(4)P recognition in the sterol transport activity of Osh4p.
In yeast, PI(4)P is synthesized by two PI-4 kinases: Pik1p 
at the trans Golgi, and Stt4p at the PM (Strahl and Thorner, 
2007). The bulk lipid composition of these compartments 
is complex and obviously not properly mimicked by accep-
tor liposomes containing only DOPC and PI(4)P. Compared 
with the ER, the PM is highly enriched in phosphatidylserine 
(Yeung et al., 2008) and contains more saturated lipids (Zinser 
et al., 1991; Schneiter et al., 1999; Pichler et al., 2001; Klemm 
et al., 2009). The trans Golgi probably displays intermediate 
features between the ER and the PM. To address the influence 
of lipid packing and membrane electrostatics, we compared 
three acceptor liposome compositions: DOPC (low packing), 
without an excess of ergosterol (Fig. 5 B). With DOPC lipo-
somes, the decay in FRET between DHE and DNS-Osh4p in-
dicated a slow (t1/2 = 188 s) replacement of DHE by ergosterol.   
In contrast, Osh4p rapidly exchanged DHE for ergosterol 
(t1/2 < 5 s) on liposomes containing 2% PI(4)P, PI(4,5)P2, or 
30% DOPS. This implied that Osh4p was able to quickly release 
DHE on liposomes containing anionic lipids. However, when 
we repeated these experiments with liposomes devoid of er-
gosterol, DHE appeared poorly delivered, except when PI(4)P 
was present. These results indicate that DHE release on anionic 
liposomes can be followed by recapture of another sterol mol-
ecule, leading to futile exchange. What makes PI(4)P unique 
compared with other anionic lipids is its ability to block sterol 
re-extraction by being loaded by Osh4p. As such, PI(4)P en-
sures net delivery of sterol.
Fast DHE transport from  
neutral membranes to  
PI(4)P-containing membranes
Osh4p optimally solubilized DHE from neutral membranes and 
fully delivered DHE to PI(4)P-containing membranes. These 
results prompted us to recapitulate sterol transport by Osh4p 
from the first to the second type of liposome. For this, donor 
liposomes made of DOPC and containing 10% DHE and 2.5% 
DNS-phosphatidylethanolamine (DNS-PE) were incubated with 
a ninefold excess of acceptor liposomes and with Osh4p. Al-
though the FRET decrease between DHE and DNS-PE moni-
tored DHE extraction from the donor liposomes (John et al., 
2002), a decrease of 60% as seen in Fig. 6 A necessarily 
implies DHE delivery to the acceptor liposomes and Osh4p re-
cycling through multiple cycles of transport. Indeed, Osh4p was 
used in a substoichiometric amount compared with DHE (ratio 
1:20). Without acceptor liposomes, only minor FRET decrease 
was observed (see Materials and methods).
Fig. 6 A shows DHE transport experiments where we varied 
the composition of the acceptor liposomes. When these liposomes 
Figure 5.  Osh4p delivers DHE to PI(4)P-containing liposomes. (A) Osh4p loaded with DHE (0.5 µM Osh4p[DHE]) was incubated at 30°C in buffer. At 
the indicated time, 30 µl of a stock suspension of liposomes (5 mM lipids) was injected (final concentration = 240 µM). The release of DHE was followed 
by measuring the increase in Osh4p fluorescence at 340 nm (ex = 285 nm). The liposomes contained DOPC and, when indicated, 2 mol% of DOPS, 
PI, PI(3)P, PI(4)P, PI(5)P, or PI(4,5)P2. (B) DNS-Osh4p loaded with DHE (0.5 µM) was mixed with 240 µM liposomes with (left) or without (right) 5 mol% 
ergosterol at 30°C. The release of DHE was followed by measuring the diminution in FRET between DHE and DNS (ex = 310 nm; em = 510 nm). In all 
assays, the recordings were corrected for the light-scattering signal and the dilution effect was due to liposome addition.JCB • VOLUME 195 • NUMBER 6 • 2011   972
Counter exchange of PI(4)P and DHE  
by Osh4p
PI(4)P could be very efficiently extracted by Osh4p (Fig. 3),   
had a stimulatory effect on DHE delivery (Fig. 5), and strongly 
accelerated the rate of DHE transport under multiple turnover 
conditions (Fig. 6). Together, these observations suggested that 
DHE transport from donor to acceptor liposomes may be cou-
pled to transport of PI(4)P in the opposite direction. Interest-
ingly, this prediction could explain the atypical shape of DHE 
transport kinetics: in the presence of PI(4)P in the acceptor 
liposomes, the time courses slowed down abruptly once half 
of DHE had been transferred (Fig. 6, A and C). PI(4)P, which 
promotes DHE delivery on the acceptor liposomes, should, if 
transported back to the donor liposomes, become inhibitory by 
competing with DHE for Osh4p extraction.
We set up an indirect assay for PI(4)P transport. In a first 
step, we mixed Osh4p with two liposome populations: “A1” 
containing 6% PI(4)P, and “A2” without PI(4)P. Given the ratio 
between these liposomes (1:5), transport and equilibration of 
DOPC/DOPS (low packing and high charge density), and   
1-palmitoyl-2-oleoyl-phosphatidylcholine  (POPC)/1-palmitoyl- 
2-oleoyl-phosphatidylserine (POPS; medium packing and high 
charge density). In all cases, we observed a strong stimulatory 
effect of 2% PI(4)P on DHE transport, which suggests that 
PI(4)P retains a specific effect on Osh4p regardless of the bulk 
properties of the acceptor membrane (Fig. 6 C). However, the 
rate of DHE transport decreased by one order of magnitude 
when the acceptor liposomes combined low lipid packing and 
high charge density. Because the PI(4)P-dependant sterol de-
livery step was marginally affected by these changes (Fig. S4),   
the following step of the cycle, recycling of Osh4p from DOPC/
DOPS liposomes, should be rate limiting. This effect is explained 
by the fact that Osh4p is strongly retained on these liposomes, 
as previously observed (Figs. 2 and S2). Finally, we noticed that 
transport occurred in all conditions without liposome aggregation 
(Fig. S4, B and C). Thus, Osh4p efficiently transfers sterol from 
neutral membranes to membranes containing PI(4)P and a high 
density of other anionic lipids without membrane bridging.
Figure  6.  Osh4p  optimally  transports  DHE 
from neutral to PI(4)P-containing membranes. 
(A)  Effect  of  anionic  lipids  in  the  acceptor   
liposomes.  DOPC/DNS-PE/DHE  liposomes 
(87.5:2.5:10 mol/mol, 100 µM lipids) were 
mixed with DOPC liposomes (900 µM lipids) 
containing  2  mol%  of  the  indicated  lipid.   
After 3 min, 0.5 µM Osh4p was added. FRET 
between DHE and DNS-PE in the donor lipo-
somes diminishes as DHE is transported to the 
acceptor  liposomes.  The  initial  fluorescence 
signal was set at 100%. The slow decay ob-
served  without  Osh4p  is  caused  by  sponta-
neous  DHE  transfer  between  the  liposomes.   
(A, right) Initial transport rates. (B) Osh4p WT 
or mutants (0.5 µM) were added to DOPC/
DNS-PE/DHE liposomes (87.5:2.5:10 mol/mol, 
100 µM lipids) mixed with DOPC liposomes 
(900 µM lipids) containing 0, 1, or 2% PI(4)P. 
The initial transport rates are indicated on a 
linear scale for each mutant (black bars, 0% 
PI(4)P; dark red bars, 1% PI(4)P; red bars, 2% 
PI(4)P).  The  broken  lines  correspond  to  the 
value of the initial transport rate measured for 
the wild-type Osh4p with acceptor liposomes 
containing 1% or 2% PI(4)P. Data are repre-
sented as mean ± SEM (error bars; n = 2).   
(C) Transport was measured by mixing 0.5 µM 
Osh4p  with  DOPC/DNS-PE/DHE  liposomes 
(87.5:2.5:10  mol/mol,  100  µM  lipids)  and 
acceptor liposomes (900 µM lipids) of differ-
ent  compositions  (DOPC,  DOPC/DOPS  or 
POPC/POPS 70:30 mol/mol) with 2% PI(4)P 
(red  traces)  or  without  PI(4)P  (black  traces).   
(C, right) Initial transport rate. Black bars, with-
out PI(4)P; red bars, with 2% PI(4)P. Experi-
ments in A and C were completed once but 
include common conditions.973 Osh4p is a sterol/PI(4)P transporter • de Saint-Jean et al.
Discussion
Identifying the mechanisms by which lipid transfer proteins 
selectively convey lipids between membranes is crucial for   
understanding how organelles maintain their composition (Lev, 
2010). Osh4p has been suggested to transport sterol from the PM, 
marked by PI(4,5)P2, to the ER (Raychaudhuri et al., 2006). We 
propose a different model in which Osh4p physically exchanges 
sterols for PI(4)P between membranes. Based on structural and 
biochemical data, this model reconciles several cellular obser-
vations on Osh4p and suggests that the distribution of sterol 
may be controlled by phosphoinositide metabolism.
Osh4p efficiently solubilizes PI(4)P from membranes and, 
for this, uses roughly the same binding site as for sterol extrac-
tion. This unexpected finding is nicely explained by the struc-
ture of Osh4p bound to PI(4)P. First, the sterol-binding pocket 
accommodates the PI(4)P acyl chains. Second, a shallow pocket 
at the entrance of the tunnel, which contains critical residues 
such as K336 and the H143/H144 pair, selects the polar head of 
PI(4)P with high specificity. This interaction is probably essen-
tial for compensating loose binding of the PI(4)P acyl chains. 
Third, the N-terminal lid secures the bound PI(4)P molecule by 
wrapping its glycerol moiety. Overall, the result of these three 
interactions is functionally very important: Osh4p displays a 
similar affinity for PI(4)P and sterols.
Our kinetic analysis suggests that Osh4p is designed to 
promote rapid exchange of sterols for PI(4)P between membranes 
according to the cycle shown in Fig. 8. In this scheme, sterol re-
lease in the acceptor membrane is followed by PI(4)P extrac-
tion; conversely, PI(4)P release in the donor membrane precedes 
sterol extraction. When integrated in a more general view in-
cluding other lipid-modifying enzymes and lipid transporters at 
PI(4)P between A1 and A2 by Osh4p should lead to a final den-
sity of 1 mol% accessible PI(4)P. Thereafter, donor liposomes 
(D) containing DHE were added. Because only A2 contained 
the fluorescent lipid DNS-PE, the FRET signal monitored DHE 
transport from D to A2. As shown in Fig. 7 A, the kinetic of 
DHE transport was almost as fast as in a control reaction per-
formed with 1 mol% PI(4)P directly included in liposomes A2. 
In contrast, when A1 liposomes were devoid of PI(4)P, the de-
livery of DHE to A2 was very slow. This assay suggested that 
Osh4p had efficiently transported PI(4)P from A1 to A2 during 
the first step.
Next, we devised a direct assay for PI(4)P transport based 
on liposome separation. Donor liposomes containing 2% DHE 
were loaded with sucrose and labeled with NBD-PE. Acceptor 
liposomes containing 2% radiolabeled PI(4)P were doped with 
rhodamine-phosphatidylethanolamine (Rhod-PE). The liposomes 
were mixed in a 1:1 ratio, incubated with or without Osh4p, and 
then separated by centrifugation. We collected a bottom and top 
fraction containing, respectively, mostly donor (80%) or accep-
tor liposomes (90%), as estimated by the relative fluorescence 
of NBD-PE and Rhod-PE. We determined that the donor lipo-
somes lost 25% DHE and gained 12–13% PI(4)P when incu-
bated with Osh4p. Conversely, the acceptor liposomes showed 
an increase in DHE and a decrease in PI(4)P (Fig. 7 B). If for-
ward transport of sterol was strictly coupled with backward trans-
port of PI(4)P, the same amount of PI(4)P and DHE should have 
been displaced. However, DHE also spontaneously exchanges be-
tween liposomes (see, e.g., the gray trace in Fig. 6 A), making 
quantitative comparisons difficult with this assay, which also 
lacks time resolution. Notwithstanding these limitations, these 
experiments indicate that Osh4p can transport DHE and PI(4)P 
in opposite ways.
Figure  7.  Osh4p  transfers  PI(4)P  between 
membranes. (A) 0.5 µM Osh4p was mixed 
at 30°C with DOPC liposomes containing 6% 
PI(4)P (liposome A1, 15 µM) and DOPC lipo-
somes doped with 2.5% DNS-PE (A2, 75 µM). 
In a second step, DOPC liposomes contain-
ing 18% DHE were added (donor liposome, 
90 µM). Control experiments were done with 
A1  and  A2  liposomes  containing  either  0 
or 1% PI(4)P (black and dark red trace, re-
spectively)  or  without  Osh4p  (gray  trace).   
(B)  Sucrose-loaded  DOPC/DHE  liposomes 
(98:2 mol/mol, 0.5 mM lipids, labeled with 
0.1%  mol  NBD-PE)  were  incubated  with 
DOPC/PI(4)P liposomes doped with [
32P]PI(4)P 
(98:2 mol/mol, 0.5 mM lipids, labeled with 
0.1 mol% Rho-PE). After centrifugation on a 
sucrose gradient, a bottom and top fraction 
were collected. The fluorescence of NBD-PE, 
Rho-PE, and DHE was measured and PI(4)P 
radioactivity was counted for each fraction. 
(B, bottom) The relative amount of donor and 
acceptor liposomes in each fraction. (B, top) 
The gain or loss of DHE and PI(4)P (in percent-
ages) for each liposome population. Data are 
represented as mean ± SEM (n = 2).JCB • VOLUME 195 • NUMBER 6 • 2011   974
explain. The fact that Osh4p also acts as a PI(4)P transporter 
suggests that cell survival upon deletion of OSH4 and SEC14 is 
caused by reduced backward transport of PI(4)P from the trans 
Golgi to the ER. Elimination of this transport pathway prob-
ably compensates for the limiting amount of PI(4)P that can be 
synthesized by Pik1p when forward transport of PI by Sec14p 
is impaired (Fairn et al., 2007). Again, this model better ex-
plains mutagenesis data: Osh4p mutants that are unable to ex-
tract PI(4)P but behave normally for sterol extraction (K336A, 
H143A/H144A)  are  not  lethal  in  Sec14p-deficient  yeast,  in 
contrast to the wild-type form (Im et al., 2005).
In conclusion, we propose a phosphoinositide cycle in 
which Sec14p and Osh4p transport PI and PI(4)P along oppo-
site routes, PI(4)P being converted into PI at the ER by Sac1p 
and PI being phosphorylated into PI(4)P at the trans Golgi by 
Pik1p (Fig. 8). When considered from the sole “point of view” 
of phosphoinositides, this cycle seems futile: ATP is used to 
continually regenerate PI(4)P. However, from a sterol-centric 
point of view, the consumption of ATP by Pik1p ensures net 
transfer of sterol in the forward direction and PC in the back-
ward direction. As such, Osh4p could drive sterols up a concen-
tration gradient and promote sterol enrichment of membranes of 
the late secretory pathway (TGN, PM) at the expense of the ER, 
where sterol is synthesized.
Some aspects of the proposed Osh4p cycle warrant further 
examination. Notably, the mechanism by which Osh4p targets 
the ER remains to be addressed. Osh4p quickly (t1/2 of 7 s) 
and totally solubilizes DHE from neutral (DOPC) liposomes 
under conditions where DHE was present at only 0.5 mol%. Thus, 
Osh4p should be able to efficiently pick up sterol from the ER, 
wherein this lipid is rare. Interestingly, we found previously that 
the lid of Osh4p corresponds to an ALPS motif (Drin et al., 2007). 
ALPS are unstructured sequences that fold into amphipathic   
helices upon binding to neutral membranes whose composition 
and high curvature result in loose lipid packing. The ER, which 
is characterized by a low content of anionic lipids, a high 
content of unsaturated lipids, and a highly tubulated structure, 
the ER–Golgi interface, the proposed cycle explains several   
genetics and cellular observations as detailed (Fig. 8).
Osh4p rescues yeast lacking the entire Osh family by re-
storing the level of sterol at the PM (Beh and Rine, 2004). By 
exchanging sterol for PI(4)P, Osh4p might supply the trans Golgi 
and PM, pinpointed by this phosphoinositol phosphate, with 
sterol. The coupling between sterol delivery and PI(4)P extraction 
also explains why mutants such as K336A and H143A/H144A,   
although fully competent for sterol extraction, do not rescue 
Osh-depleted yeast (Im et al., 2005). These mutants do not pro-
mote net transfer of sterol to the PM because they are unable to 
capture, in turn, PI(4)P.
Osh4p overexpression reduces both the cellular level of 
PI(4)P and the Golgi targeting of a PI(4)P reporter (Fairn et al., 
2007). These observations can be explained by retrograde trans-
port of PI(4)P from the Golgi to the ER by Osh4p, where PI(4)P 
is metabolized by Sac1p, an ER-resident PI(4)P-phosphatase. 
We note that this mechanism offers an alternative explanation 
for the interplay between Osh4p and Sac1p. Osh proteins have 
been proposed to facilitate the hydrolysis of PI(4)P in “trans” 
by Sac1p by forming membrane contact sites between organ-
elles (Stefan et al., 2011). This mechanism is appealing in the 
case of Osh proteins with additional domains that can effec-
tively bridge two membranes. However, Osh4p lacks such do-
mains and efficiently exchanges sterol for PI(4)P between 
liposomes without tethering them. Therefore, we hypothesize 
that Osh4p supplies the ER with PI(4)P, which is then hydro-
lyzed by Sac1p.
Finally, the sterol/PI(4)P transfer activity of Osh4p gives 
a straightforward explanation for the long-established genetic 
interactions between OSH4, SEC14, SAC1, and PIK1 genes 
(Fang et al., 1996; Li et al., 2002; Fairn et al., 2007). SEC14 
encodes for a PI/phosphatidylcholine (PC) transfer protein and 
is an essential gene. However, yeast cells can survive when 
SEC14 is inactivated together with OSH4. As long as Osh4p 
was  considered  as  a  mere  sterol  transporter,  the  functional 
antagonism between Osh4p and Sec14p remained difficult to 
Figure  8.  Model  for  the  coupling  between 
sterol and PI(4)P exchange by Osh4p. Osh4p 
solubilizes sterols efficiently from neutral and 
loosely packed membranes. The sterol is locked 
by the lid. The interaction of Osh4p with an-
ionic membranes promotes the opening of the 
lid and sterol release. Only PI(4)P promotes net 
sterol delivery because PI(4)P is extracted by 
Osh4p at the expense of sterol re-extraction. 
Tight lipid packing in the acceptor membrane 
limits the retention of Osh4p through its ALPS 
motif. These observation suggest that Osh4p 
is suited to transport sterols preferentially from 
ER to the trans Golgi marked by PI(4)P. Con-
versely, Osh4p transports PI(4)P from the trans 
Golgi to the ER, and another round of trans-
port can resume. Although each step of the 
cycle is reversible by itself, the presence of a 
PI-4 kinase at the TGN (Pik1p) and of a PI(4)P 
phosphatase at the ER (Sac1p) favors direc-
tionality  of  lipid  transport.  The  sterol/PI(4)P 
exchange activity of Osh4p is also coupled to 
that of Sec14p, a PC/PI exchanger.975 Osh4p is a sterol/PI(4)P transporter • de Saint-Jean et al.
PI(4)P  (l--PI-4-phosphate),  brain  PI(4,5)P2  (l--PI-4,5-bisphosphate),  liver 
PI (l--PI), DNS-PE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(5-
dimethylamino-1-naphthalenesulfonyl)), NBD-PE (1,2-dioleoyl-sn-glycero- 
3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl)), and Rhod-PE 
(1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B 
sulfonyl)) were obtained from Avanti Polar Lipids, Inc. PI(3)P (1,2-dioleoyl-
sn-glycero-3-inositol-3-phosphate)  and  PI(5)P  (1,2-dioleoyl-sn-glycero-3-
inositol-5-phosphate)  were  obtained  from  Echelon.  Ergosterol  and  DHE 
were obtained from Sigma-Aldrich. The concentration of DHE in stock solu-
tion in methanol was carefully determined by UV spectroscopy using an 
extinction coefficient of 13,000 M
1cm
1.
The radioactive lipids [
3H]cholesterol, [
3H]PI, and [
3H]PI(4,5)P2 were 
purchased from PerkinElmer. To prepare radioactive [
32P]PI(4)P, BHK cells 
were labeled with 1 mCi/ml ortho[
32P]phosphate during 36 h in phos-
phate-free DME containing 2% FCS. After one washing step in cold PBS, 
cells were scrapped off and recovered in 3 ml of HCl (1.6 N). A mixture of 
methanol and chloroform (6 ml, vol/vol) was immediately added and the 
sample was vortexed vigorously during 2 min and centrifuged at 300 g for 
5 min. The organic phase was collected and dried under a nitrogen stream 
at 37°C. Lipids were resolved by thin layer chromatography (TLC silica gel 
60; Merck) using CHCl3/CH3OH/NH4OH 4N (90/70/20, vol/vol) as a 
solvent and identified using appropriate standards. The spot of [
32P]PI(4)P 
was scraped off and the lipid was extracted from the silica by a modified 
Blight and Dyer procedure (Bligh and Dyer, 1959). The purity of the PI(4)P 
preparation was analyzed by HPLC. In brief, an aliquot of the preparation 
was deacylated by adding 1 ml of methylamine reagent composed of 26.8%   
(vol/vol) of 40% methylamine, 45.7% (vol/vol) methanol, 11.4% (vol/vol) 
n-butanol, and 16% (vol/vol) H2O. After incubation at 53°C for 50 min, the 
methylamine reagent was completely evaporated under a nitrogen stream 
at 37°C. The samples were resuspended in 1.2 ml H2O and separated 
by HPLC using a Whatman Partisphere 5 SAX column 4.6 mm × 125 mm 
with guard-cartridge anion exchanger units (Ref. 4641 0005; GE Health-
care) and a gradient of 1 M (NH4)2HPO4, pH 3.8, and bi-distilled water 
(Payrastre, 2004). The amount of purified PI(4)P was quantified by phos-
phorus measurement (Fiske and Subbarow, 1925).
Liposomes
Lipids in stock solutions in chloroform were mixed at the desired molar 
ratio, and the solvent was removed in a rotary evaporator. For formulations 
containing phosphoinositides, the mixture was warmed at 30–33°C for 
5 min prior to drying under vacuum. For lipid films containing radioactive 
lipids, the mixture was dried in a hemolysis tube under argon. The lipid 
film was hydrated in 50 mM Hepes, pH 7.2, and 120 mM potassium ace-
tate (HK buffer) to give a suspension of large multilamellar liposomes (lipid 
concentration: 1–5 mM). The suspension was then frozen and thawed 
five times (using liquid nitrogen and a water bath) and extruded through 
polycarbonate filters of 0.2-µm pore size using a mini-extruder (Avanti 
Polar Lipids, Inc.). For experiments with liposomes of varying curvature, 
the liposomes were extruded sequentially through 0.4-, 0.2-, 0.1-, 0.05-, 
and 0.03-µm (pore size) polycarbonate filters. The liposome hydrodynamic   
radius (RH) was estimated by dynamic light scattering in a DynaPro instru-
ment (Wyatt Technology). Liposomes were stored at 4°C and in the dark 
when containing light-sensitive lipids (NBD-PE, DNS-PE, DHE, or ergos-
terol) and used within 2 d.
DHE loading assay
For  kinetics  measurements,  Trp  fluorescence  was  measured  at  340  nm 
(bandwidth 5 nm) upon excitation at 286 nm (bandwidth 1.5 nm) in a fluor-
ometer (RF 5301-PC; Shimadzu). The sample initially contained liposomes 
(500 µM total lipids) in HKMD buffer (50 mM Hepes, pH 7.2, 120 mM 
potassium-acetate, 1 mM MgCl2, and 1 mM DTT). The liposomes used in this 
assay were extruded on a 0.2-µm filter. The sample (volume 600 µl) was 
placed in a cylindrical quartz cell, continuously stirred with a small mag-
netic bar, and thermostated at 30°C. At the indicated time, Osh4p or NBD-
Osh4p was injected from stock solutions through a guide in the cover of the 
fluorometer adapted to Hamilton syringes, such as to not interrupt the fluor-
escence recording. Emission spectra were recorded at the end of the kinet-
ics upon excitation at 285 nm. Loading experiments with DNS-Osh4p were 
performed under the same conditions except that DHE was directly excited 
at 310 nm (bandwidth 1.5 nm) and the fluorescence of DNS was followed 
at 510 nm (bandwidth 10 nm). We assessed, under conditions where 
Osh4p was strongly bound to the liposomes (i.e., with DOPC/DOPS lipo-
some), that the FRET signal reflected only DHE loading by Osh4p and not 
the proximity between the protein and DHE embedded in the membrane. In-
deed, no FRET occurred when we incubated DNS-Osh4p with DOPS/DOPS 
liposomes containing DHE (0.5%) and an excess of ergosterol (5%).
seems well adapted to the transient adsorption of the Osh4p 
ALPS/lid region. In the future, it will be important to study in a 
systematic manner the influence of membrane curvature and 
composition on the ability of Osh4p to exchange sterol and 
PI(4)P between membranes. In fact, one reason for the conflict-
ing results between this study and previous studies may be related 
to membrane curvature. In several in vitro assays for Osh4p trans-
port, very small liposomes obtained by sonication and contain-
ing high amounts of anionic lipids have been used (Raychaudhuri 
et al., 2006; Schulz et al., 2009; Stefan et al., 2011). It is likely 
that the combination of extreme curvature and high electrostatic 
favors Osh4p retention on the liposomes, impairs lipid transport, 
and causes membrane aggregation through the multiple potential 
membrane-binding sites of Osh4p (ALPS motif, basic patches).
Most of residues that contact the PI(4)P headgroup are 
conserved in Osh/Orp proteins, which suggests that extraction 
of PI(4)P is a general hallmark of this family. Determining how 
this biochemical feature translates to a function will require 
further investigation for each Osh/Orp.
Materials and methods
Proteins
Osh4p and Osh4p[30–434] were cloned in a pGEX-4T-3 vector. Site-specific 
mutations were introduced using the QuikChange mutagenesis protocol 
and checked by DNA sequencing. Osh4p was expressed in E. coli at 30°C 
overnight upon induction with 1 mM IPTG (OD600 = 0.6). All purification 
steps were conducted in 50 mM Tris, pH 7.4, 120 mM NaCl, 1 mM MgCl2, 
and 1 mM DTT supplemented, during the first purification steps, with 1 mM 
PMSF, 1 µM bestatine, 10 µM pepstatine, 10 µM phosphoramidon, and 
protease inhibitor tablets (Roche). Cells were lysed with a French press and 
the lysate was centrifuged at 200,000 g for 1 h. The supernatant was ap-
plied to Glutathione Sepharose 4B beads. After three washing steps, the 
beads were incubated with thrombin to cleave the GST fusion and allow the 
release of Osh4p. The purity of the proteins was >95% as assessed by SDS-
PAGE. The protein concentration was determined by a Bradford assay and 
by SDS-PAGE analysis using a BSA standard curve. All constructs contain an 
N-terminal GS sequence from the thrombin cleavage site.
5-((((2-iodoacetyl)amino)ethyl)amino)naphthalene-1-sulfonic  acid 
(IAEDANS) labeling of Osh4p was performed by mixing the protein (after 
DTT removal by dialysis) with a 10-fold molar excess of IAEDANS (Invitro-
gen). After 90 min on ice, the reaction was stopped by adding a 10-fold   
excess of l-cysteine over the probe. The free probe was removed by gel 
filtration on a Sephacryl S200 HR XK16-50 column (GE Healthcare). The 
labeled  protein  was  analyzed  by  SDS-PAGE  and  UV-visible  spectros-
copy. The gel was directly visualized in a fluorescence imaging system   
(U-GENIUS; Syngene) to detect DNS-labeled Osh4p excited in near-UV 
and then stained with Sypro Orange to determine the purity of DNS-Osh4p. 
The percentage of labeling was estimated from the optical density (OD)   
of tryptophan at 280 nm ( = 73,900 M
1cm
1) and DNS at 340 nm   
( = 5,700 M
1cm
1). In a control experiment, we observed no labeling of 
the Osh4p(C98S) mutant, which indicates that CYS-98 was the sole endog-
enous cysteine that could be labeled by a thiol-reactive probe.
NBD labeling of Osh4p was performed on a double mutant lacking 
the solvent-exposed endogenous cysteine (C98S) and including a cysteine 
in the N-terminal lid (A5C). After DTT removal, this mutant was labeled 
with a 10-fold excess of N,N’-dimethyl-N-(iodoacetyl)-N’-(7-nitrobenz-
2-oxa-1,3-diazol-4-yl)ethylenediamine (IANBD-amide; Invitrogen) and pu-
rified according to the instructions used for DNS-Osh4p. The percentage of 
labeling was estimated from the optical density at 280 and 495 nm ( = 
25,000 M
1cm
1 for NBD according to the manufacturer). The PH domain 
of FAPP in fusion with GST was provided by J. Bigay (Centre National   
de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellu-
laire, Valbonne, France).
Lipids
DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine), POPC (1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine),  DOPS  (1,2-dioleoyl-sn-glycero-3-phospho- 
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(150 µl), and top (100 µl) fractions were collected. The bottom and top 
fractions were analyzed by SDS-PAGE using Sypro-Orange staining and a 
fluorescence imaging system (LAS-3000; Fujifilm).
DHE/PI(4)P transport experiments
0.5 µM Osh4p was incubated for 30 min at 30°C under constant mixing 
in 125 µl HKM buffer with DOPC/DHE liposomes (98:2 mol/mol, 500 µM   
total lipids) doped with NBD-PE, then loaded with 50 mM Hepes, pH 7.2, 
220 mM sucrose, and DOPC/PI(4)P liposomes (98:2 mol/mol, 500 µM 
total lipids) doped with Rhod-PE and [
32P]PI(4)P. The suspension was ad-
justed to 7.5% sucrose by mixing 75 µl of a 20% (wt/vol) sucrose solution 
in HKM buffer and overlaid with three cushions of 200 µl HKM containing 
5, 2.5, and 0% (wt/vol) sucrose. The sample was centrifuged at 240,000 g 
in a TLS 55 rotor for 1 h at 4°C. The bottom and top fractions (400 µl each) 
were collected. Emission fluorescence spectra of NBD-PE, Rhod-PE, and 
DHE were measured in a 100-µl quartz cell (DHE, from 325 to 450 nm,   
excitation at 310 nm; NBD-PE, from 480 to 700 nm, excitation at 470 nm; 
Rhod-PE, from 580 to 700 nm, excitation at 570 nm) to quantify DHE, 
donor  liposomes,  and  acceptor  liposomes,  respectively.  Samples  were 
then mixed with 2 ml scintillant and counted to measure PI(4)P. For each 
fraction, we determined the percentage of transferred DHE by considering 
%TDHE = DHE/TDHE × (FA  FD), where DHE is the difference in DHE fluor-
escence between the samples with and without Osh4p, TDHE is the mean 
total DHE fluorescence measured for both experiments, and FD and FA are 
the relative amounts of donor and acceptor liposomes in one fraction. 
Because of the small contamination of one population of liposome by the 
other, gain of DHE in one population is compensated by loss of DHE in 
the second population and leads to an apparent variation in DHE that is 
lower than the real transfer. Similarly, the percentage of transferred PI(4)P 
was calculated on the basis of radioactivity considering that %TPI(4)P =   
PI(4)P/TPI(4)P × (FD  FA).
Dynamic light scattering
Experiments were performed at 30°C in a DynaPro apparatus (Protein 
Solutions). The sample initially contained donor and acceptor liposomes 
in HKMD buffer in a small quartz cell (volume 20 µl). A first set of 12 
autocorrelation curves was acquired to assess the size distribution of 
the initial liposome suspension. Then, Osh4p was added manually and 
mixed thoroughly, and the kinetics of aggregation was followed by ac-
quiring one autocorrelation curve every 10 s. The data were analyzed 
by the Dynamics v6.1 software (Protein Solutions) by fitting the autocor-
relation functions with the assumption that the size distribution is a simple 
Gaussian function.
Crystallization and x-ray data collection
6  mg/ml  Osh4p  was  incubated  for  2  h  with  large  DOPC  liposomes 
containing 2% PI(4)P and loaded with sucrose (12 mM total lipids). The 
sample (2 ml) was centrifuged at 400,000 g for 20 min at 4°C in a fixed-
angle rotor (TLA 100.1) to separate the protein loaded with PI(4)P from 
liposomes. The Osh4p–PI(4)P complex recovered in the supernatant was 
purified by gel filtration on a Sephacryl S200 HR XK16-50 column and 
concentrated at 9.7 mg/ml. The Osh4p–PI(4)P complex was crystallized 
by the hanging drop vapor diffusion method where 1 µl of protein sample 
in 20 mM Tris, pH 8.0, and 100 mM NaCl was mixed to 1 µl of reservoir 
solution containing 100 mM MES, pH 7.0, 250 mM CaCl2, and 16% PEG 
at 18°C. Native diffraction data from one crystal cryoprotected with 20% 
glycerol were collected to 2.6-Å resolution at a wavelength of 0.9334 Å 
on the ID14-1 beamline at the European Synchrotron Radiation Facility. 
Data were processed and scaled with XDS and XSCALE (Kabsch, 2010). 
The PI(4)P-bound Osh4p crystallized in the space group P21 with cell pa-
rameters a = 73.46 Å, b = 54.76 Å, c = 121.86 Å, and  = 91°, with 
two molecules per asymmetric unit.
X-ray structure determination and refinement
The x-ray structure was determined by the molecular replacement method 
using PHENIX (Adams et al., 2010) and the structure of Osh4p solved in 
complex with 20-hydroxycholesterol (PDB accession no. 1ZHW) as the 
search model. The initial structure was rebuilt using COOT (Emsley and 
Cowtan, 2004) and refined with PHENIX and REFMAC (Murshudov et al., 
1997) from the CCP4 suite (Winn et al., 2011). The R-factor of the final 
structure is 0.228 (Rfree = 0.269), using all data from 47.29- to 2.6-Å   
resolution.  Data  collection  and  refinement  statistics  are  summarized  in 
Table S1. The structure contains 398 residues for chain A and 390 resi-
dues for chain B, and the rmsd of the two subunits is 0.424 Å for 385 
superimposed  carbons. Because both structures in the asymmetric unit 
are very similar and chain A is more complete, only chain A is discussed. 
DHE extraction assay
0.5 µM Osh4p was mixed with 500 µM (total lipids) of large sucrose-loaded 
liposomes (210 mM sucrose and 50 mM Hepes, pH 7.2, extruded on a 
0.2-µm filter) for 15 min at 30°C under stirring in HKMD. The sample was 
centrifuged at 400,000 g for 20 min at 20°C in a fixed-angle rotor (TLA 
100.1; Beckman). The supernatant (600 µl) was recovered and the lipo-
some pellet was resuspended in 600 µl HKMD. A fluorescence spectrum of 
each fraction was recorded between 300 and 450 nm (bandwidth 5 nm) 
upon excitation at 285 nm (bandwidth 1.5 nm). The background signal 
was determined by measuring spectra of buffer with or without liposomes 
(500 µM total lipids). In addition, each sample was analyzed by SDS-PAGE,   
using Sypro Orange staining and a fluorescence imaging system (LAS 3000; 
Fujifilm). Control centrifugations performed without liposomes indicated that 
Osh4p did not sediment.
DHE delivery assay
To prepare Osh4p in complex with DHE, Osh4p was incubated in HKMD 
at 2 µM for 30 min at 30°C under agitation with large DOPC liposomes 
(200 µM total lipid) loaded with sucrose and containing 10% DHE (mol/mol 
lipids). The sample was centrifuged at 400,000 g for 20 min at 20°C to pel-
let the liposomes. The supernatant (600 µl) containing Osh4p loaded with 
DHE (Osh4p[DHE]) was collected. Osh4p[DHE] was diluted at 0.5 µM in 
HKMD in a cylindrical quartz cuvette (final volume 600 µl). Sterol delivery 
was monitored at 340 nm (bandwidth 10 nm) upon excitation at 285 nm 
(bandwidth 1.5 nm) at 30°C by adding 30 µl of large liposomes (stock 
solution 5 mM, final concentration 240 µM) to Osh4p[DHE]. The protocol 
used to measure DHE release from DNS-Osh4p was the same except that 
the signal was measured at 510 nm (bandwidth 20 nm) upon excitation at 
310 nm (bandwidth 1.5 nm).
DHE transport assay
A suspension (570 µl) of acceptor liposomes (900 µM total lipids) was incu-
bated in a cylindrical cuvette at 30°C under constant stirring. After 1 min, 
30 µl donor liposomes (100 µM lipid, final concentration) containing 2.5% 
of DNS-PE and 10% of DHE was added. The liposomes were extruded on a 
0.2-µm filter. After 3 min, Osh4p was injected at 0.5 µM. Lipid transport 
was followed by measuring the DNS signal at 525 nm (bandwidth 10 nm) 
upon DHE excitation at 310 nm (bandwidth 1.5 nm). The amplitude of the 
signal corresponding to maximal transport of DHE was determined by add-
ing 1 mM of methyl--cyclodextrin. The linear dependency of the FRET signal 
on the DHE content was checked by measuring at 525 nm the fluorescence 
of a set of DOPC liposomes containing 2.5% of DNS-PE and 0, 2, 4, 6, 8, 
or 10% DHE. In the absence of acceptor liposomes, the addition of Osh4p 
resulted in a FRET decrease of only 5–10% as compared with 60% in the 
presence of acceptor liposomes, which indicates the extraction of a small 
amount of DHE from donor liposomes by the protein.
Lipid and cholesterol extraction assay
Sucrose-loaded liposomes (500 µM total lipids, extruded on 0.2 µm filter) 
containing 0.4% Rhod-PE and the indicated radiolabeled lipid were mixed 
with increasing amount of Osh4p (0–5 µM) for 20 min at room temperature. 
The sample was centrifuged at 400,000 g for 20 min at 20°C in a fixed-
angle rotor (TLA 100.1). The supernatant (150 µl) was recovered and the 
liposome pellet, which could be easily visualized owing to the presence of 
Rhod-PE, was resuspended in 150 µl HKMD. Both samples were mixed with 
2 ml scintillant and counted.
NBD-fluorescence lipid binding assay
0.5 µM NBD-Osh4p was incubated at 30°C for 5 min with liposomes 
(500 µM total lipids) in HKMD buffer. Emission fluorescence spectra 
were measured from 505 to 650 nm (bandwidth 5 nm) upon excitation 
at 495 nm (bandwidth 5 nm) in a 100-µl quartz cell. Control spectra 
were also recorded in the absence of protein to subtract the light-scattering 
signal of the liposomes from the protein spectra. To measure NBD fluor-
escence over time, the sample was excited at 495 nm (bandwidth 5 nm) 
and the emission was recorded at 525 nm (bandwidth 5 nm).
Flotation experiments
The protocol has been described in detail (Bigay and Antonny, 2005; 
Bigay et al., 2005). In brief, 0.75 µM of protein was incubated with NBD-
PE–containing liposomes (750 µM total lipids) in 150 µl HKM buffer (HK 
buffer with 1 mM MgCl2) at room temperature for 5 min. The suspension 
was adjusted to 30% sucrose by mixing 100 µl of a 75% (wt/vol) sucrose 
solution in HKM buffer and overlaid with 200 µl HKM containing 25% 
(wt/vol) sucrose and 50 µl sucrose-free HKM. The sample was centrifuged 
at 240,000 g in a swing rotor (TLS 55) for 1 h. The bottom (250 µl), middle 977 Osh4p is a sterol/PI(4)P transporter • de Saint-Jean et al.
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Molecular modeling
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studies. The 3D structure of the molecule PI(4,5)P2 has been built by using 
the 3D structure of PI(4)P in its crystallographic binding mode.
Online supplemental materials
Fig.  S1  shows  by  fluorescence-based  approaches  that  the  lidless  [30–
434]Osh4p mutant is unable to extract DHE. Fig. S2 shows control experi-
ments indicating that the fluorescence of NBD-Osh4p at 525 nm reflects 
its avidity for membranes. Fig. S3 details the interaction between PI(4)P 
and  Osh4p,  and  shows  that  Osh4p  cannot  accommodate  a  PI(4,5)P2 
headgroup. Fig. S4 shows that whatever the electrostatic and lipid-packing 
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Table S1 gives information on the structure determination and refinement 
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